| Carrie S Keane, CNM | |
|
200 Banning St Ste 320, Dover, DE 19904-3488 | |
| (302) 674-0223 | |
| (302) 346-3443 |
| Full Name | Carrie S Keane |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 20 Years |
| Location | 200 Banning St Ste 320, Dover, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942205265 | NPI | - | NPPES |
| 1000034284 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | LK0000140 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dedicated To Women Ob-gyn, P.a. | 0446290456 | 21 |
News Archive
Successful resuscitation rates more than doubled after the Atlanta VA Medical Center instituted a program of upgrading existing defibrillators and placing automated external defibrillators (AEDs) throughout the hospital, while also educating staff, according to a new study in the Aug. 18, 2004 issue of the Journal of the American College of Cardiology.
In his first public comments about the law since last week's Supreme Court oral arguments, President Barack Obama not only defended the measure and maintained confidence that it would not be overturned, but he also offered warnings against judicial activism.
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, for the management of acute moderate-to-severe pain in adults.
Researchers at the Federal University of São Carlos in Sorocaba have developed a technique to diagnose early-stage multiple sclerosis, a disease of the central nervous system, and distinguish it from neuromyelitis optica, a rare yet severe autoimmune inflammatory process also affecting the central nervous system.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it completed the design of the Rheumatoid Arthritis (RA) Phase III study of its lead drug candidate CF101.
› Verified 6 days ago
| Entity Name | Dedicated To Women Ob-gyn, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548291891 PECOS PAC ID: 0446290456 Enrollment ID: O20050510000321 |
News Archive
Successful resuscitation rates more than doubled after the Atlanta VA Medical Center instituted a program of upgrading existing defibrillators and placing automated external defibrillators (AEDs) throughout the hospital, while also educating staff, according to a new study in the Aug. 18, 2004 issue of the Journal of the American College of Cardiology.
In his first public comments about the law since last week's Supreme Court oral arguments, President Barack Obama not only defended the measure and maintained confidence that it would not be overturned, but he also offered warnings against judicial activism.
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, for the management of acute moderate-to-severe pain in adults.
Researchers at the Federal University of São Carlos in Sorocaba have developed a technique to diagnose early-stage multiple sclerosis, a disease of the central nervous system, and distinguish it from neuromyelitis optica, a rare yet severe autoimmune inflammatory process also affecting the central nervous system.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it completed the design of the Rheumatoid Arthritis (RA) Phase III study of its lead drug candidate CF101.
› Verified 6 days ago
| Entity Name | Bayhealth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1285809509 PECOS PAC ID: 1658364740 Enrollment ID: O20081010000398 |
News Archive
Successful resuscitation rates more than doubled after the Atlanta VA Medical Center instituted a program of upgrading existing defibrillators and placing automated external defibrillators (AEDs) throughout the hospital, while also educating staff, according to a new study in the Aug. 18, 2004 issue of the Journal of the American College of Cardiology.
In his first public comments about the law since last week's Supreme Court oral arguments, President Barack Obama not only defended the measure and maintained confidence that it would not be overturned, but he also offered warnings against judicial activism.
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, for the management of acute moderate-to-severe pain in adults.
Researchers at the Federal University of São Carlos in Sorocaba have developed a technique to diagnose early-stage multiple sclerosis, a disease of the central nervous system, and distinguish it from neuromyelitis optica, a rare yet severe autoimmune inflammatory process also affecting the central nervous system.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it completed the design of the Rheumatoid Arthritis (RA) Phase III study of its lead drug candidate CF101.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carrie S Keane, CNM 200 Banning St Ste 320, Dover, DE 19904-3488 Ph: (302) 674-0223 | Carrie S Keane, CNM 200 Banning St Ste 320, Dover, DE 19904-3488 Ph: (302) 674-0223 |
News Archive
Successful resuscitation rates more than doubled after the Atlanta VA Medical Center instituted a program of upgrading existing defibrillators and placing automated external defibrillators (AEDs) throughout the hospital, while also educating staff, according to a new study in the Aug. 18, 2004 issue of the Journal of the American College of Cardiology.
In his first public comments about the law since last week's Supreme Court oral arguments, President Barack Obama not only defended the measure and maintained confidence that it would not be overturned, but he also offered warnings against judicial activism.
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, for the management of acute moderate-to-severe pain in adults.
Researchers at the Federal University of São Carlos in Sorocaba have developed a technique to diagnose early-stage multiple sclerosis, a disease of the central nervous system, and distinguish it from neuromyelitis optica, a rare yet severe autoimmune inflammatory process also affecting the central nervous system.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it completed the design of the Rheumatoid Arthritis (RA) Phase III study of its lead drug candidate CF101.
› Verified 6 days ago
Mrs. Amber Marie Garbe, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1113 S State St, Dover, DE 19901 Phone: 302-735-8720 | |
Kathryn F.l. O'brien, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 200 Banning St Ste 320, Dover, DE 19904 Phone: 302-674-0223 Fax: 302-674-0109 | |
Jenilee Jaquez, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 200 Banning St Ste 320, Dover, DE 19904 Phone: 302-674-0223 | |
Mrs. Beverly A Santana, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 200 Banning St Ste 320, Dover, DE 19904 Phone: 302-674-0223 | |
Kristina Ann Yablonski, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 200 Banning Street, Suite 320, Dover, DE 19904 Phone: 302-674-0223 Fax: 302-674-0109 | |
Laurel Frances Miller, MSN, CNM, WHNP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 200 Banning St Ste 320, Dover, DE 19904 Phone: 302-674-0223 Fax: 302-674-0109 | |
Meghan Elizabeth Miller, CNM, WHNP Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 200 Banning St, Suite 320, Dover, DE 19904 Phone: 302-674-0223 |